drugset
Drugs / Volulyte 6%
last change Jul 2022 re-read 3 minutes ago

Volulyte 6%

Other / unclassified

Developed for
acute hypotension
Investigated by
B. Braun Melsungen AG · European Society of Anaesthesiology and Intensive Care · Fresenius Kabi

Trials 1

today NCT03278548 · Ph 4
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03278548 Sep 2017 → Apr 2022 acute hypotension Fresenius Kabi Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Volulyte 6% ClinicalTrials.gov intervention name — accepted as the source's own label NCT03278548 ↗
Modality Other / unclassified “6% HES (Hydroxyethyl Starch) solution (Volulyte 6%)” NCT03278548 ↗